Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis

Kim Newton1, Debra L Dugger, Katherine E Wickliffe

  • 1Department of Physiological Chemistry, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA.

Science (New York, N.Y.)
|February 22, 2014
PubMed

Insights

Receptor-interacting protein kinase 3 (RIPK3) kinase activity is essential for necroptosis. Inactive RIPK3 unexpectedly triggered apoptosis, while inactive RIPK1 blocked necroptosis but allowed other cell signaling pathways to function.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Death Pathways

Background:

  • Receptor-interacting protein kinase 1 (RIPK1) and RIPK3 mediate necroptosis, a pro-inflammatory programmed cell death.
  • Previous studies using RIPK3-deficient mice or RIPK1 inhibitors suggested necroptosis contributes to disease pathology.

Purpose of the Study:

  • To investigate the necessity of active RIPK1 and RIPK3 kinase function in vivo.
  • To elucidate the distinct roles of RIPK1 and RIPK3 kinase activity in cell death and signaling.

Main Methods:

  • Engineering mice expressing catalytically inactive RIPK3 (D161N) and RIPK1 (D138N).
  • Assessing mouse viability, response to TNF-induced hypothermia, and cell death pathways (apoptosis and necroptosis).

Main Results:

  • Mice expressing inactive RIPK3 (D161N) exhibited lethal apoptosis dependent on RIPK1 and caspase-8.
  • Mice expressing inactive RIPK1 (D138N) were viable and resistant to TNF-induced hypothermia and necroptosis.
  • Cells with inactive RIPK1 (D138N) remained capable of TNF-induced gene transcription.

Conclusions:

  • RIPK3 kinase activity is indispensable for necroptosis.
  • RIPK3 kinase activity also regulates the switch between necroptosis and caspase-8-dependent apoptosis.
  • RIPK1 kinase activity is not essential for viability but is required for TNF-induced necroptosis.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
5.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.7K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.3K